Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Consolidated Net Income: 2023-2024

Historic Consolidated Net Income for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$161.3 million.

  • Zenas BioPharma's Consolidated Net Income fell 33.40% to -$51.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$193.8 million, marking a year-over-year decrease of 50.07%. This contributed to the annual value of -$161.3 million for FY2024, which is 334.62% down from last year.
  • Zenas BioPharma's Consolidated Net Income amounted to -$161.3 million in FY2024, which was down 334.62% from -$37.1 million recorded in FY2023.
  • Zenas BioPharma's Consolidated Net Income's 5-year high stood at -$37.1 million during FY2023, with a 5-year trough of -$161.3 million in FY2024.
  • In the last 2 years, Zenas BioPharma's Consolidated Net Income had a median value of -$99.2 million in 2023 and averaged -$99.2 million.
  • Data for Zenas BioPharma's Consolidated Net Income shows a maximum YoY crashed of 334.62% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Consolidated Net Income stood at -$37.1 million in 2023, then plummeted by 334.62% to -$161.3 million in 2024.